Shawn Tomasello
Chief Commercial Officer, Pharmacyclics.
Companies
- Cabaletta Bio, Inc.Board member Jul 24, 2023 to now1
- 4D Molecular Therapeutics, Inc.Board member Dec 10, 2020 to now2
- Kalaris Therapeutics, Inc.Board member Mar 31, 2022 to Jun 7, 20243
- Gamida Cell Ltd.Board member Jan 3, 2022 to Feb 2, 20244
- TCR2 THERAPEUTICS INC.Board member Feb 4, 2021 to Jun 1, 20235
- UroGen Pharma Ltd.Board member Jan 10, 2019 to Jun 9, 20216
- Principia Biopharma (United States)Board member Aug 30, 2019 to Sep 28, 20207
- ABEONA THERAPEUTICS INC.Board member Apr 20, 2020 to May 22, 20208
- Diplomat PharmacyBoard member Oct 9, 2015 to Feb 10, 20209
- Kite PharmaChief Commercial Officer Dec 21, 2015 to Oct 5, 201710
- PharmacyclicsChief Commercial Officer Aug 19, 2014 to May 28, 201511
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kalaris Therapeutics, Inc. KLRS70,000 shares12$133.7K at $1.91Jun 6, 2024
- Cabaletta Bio, Inc. CABA22,725 shares13$35.2K at $1.55Jan 21, 2026
- Gamida Cell Ltd.241,977 shares14Jan 31, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 21, 2026Bought 22,725 shares at $2.21 of Cabaletta Bio, Inc.13
- Jun 6, 2024Granted 35,000 shares of Kalaris Therapeutics, Inc.12
- Jan 31, 2024Granted 200,000 shares of Gamida Cell Ltd.14
- Oct 19, 2023Granted 28,300 shares of Gamida Cell Ltd.15
- May 11, 2023Granted 35,000 shares of Kalaris Therapeutics, Inc.16
- Feb 8, 2023Granted 28,300 shares of Gamida Cell Ltd.17
- Nov 18, 2022Granted 2,000 shares of Gamida Cell Ltd.18
- Sep 30, 2022Bought 9,677 shares at $1.55 of Gamida Cell Ltd.19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCabaletta Bio, Inc., Board member
- 2
- 3
- 4SEC EDGARGamida Cell Ltd., Board member
- 5SEC EDGARTCR2 THERAPEUTICS INC., Board member
- 6SEC EDGARUroGen Pharma Ltd., Board member
- 7
- 8
- 9SEC EDGARDiplomat Pharmacy, Board member
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Oct 20, 2023
- 16SEC EDGARForm 4 filed May 12, 2023
- 17SEC EDGARForm 4 filed Feb 10, 2023
- 18SEC EDGARForm 4 filed Nov 22, 2022
- 19SEC EDGARForm 4 filed Oct 4, 2022